Intercept Pharmaceuticals reported $-11094000 in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -43.87M 22.58M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Amarin AMRN:US $ 7.81M 9.43M
Amgen AMGN:US $ 464M 1182M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Arrowhead Research ARWR:US $ -29924000 3.11M
AstraZeneca AZN:LN 550M 1011M
Biogen BIIB:US $ 448.5M 38.3M
Bluebird Bio BLUE:US $ -241.7M 35.89M
Bristol Myers Squibb BMY:US $ 1055M 966M
Eli Lilly And LLY:US $ 1390.2M 34.9M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Galectin Therapeutics GALT:US $ -8.45M 2.11M
Gilead Sciences GILD:US $ 1522M 207M
GlaxoSmithKline GSK:LN 1395M 322M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -80.88M 8.99M
Moderna Inc MRNA:US 2.78B 1.56B
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Novartis NOVN:VX SF 2896M 837M
Ptc Therapeutics PTCT:US $ -118.37M 10.27M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M
Sangamo Biosciences SGMO:US $ -47.17M 1.24M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
YTE INCY:US $ 149.46M 95.92M